Overall market sentiment has been high on IMMURON LTD/S ADR (IMRN) stock lately. IMRN receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With IMRN Stock Today?
IMMURON LTD/S ADR (IMRN) stock is trading at $8.59 as of 10:50 AM on Tuesday, Sep 15, an increase of $0.70, or 8.9% from the previous closing price of $7.89. The stock has traded between $8.50 and $9.18 so far today. Volume today is below average. So far 93,019 shares have traded compared to average volume of 252,579 shares.
To screen for more stocks like IMMURON LTD/S ADR click here.
More About IMMURON LTD/S ADR
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's lead product candidate, IMM-124E, is a proprietary immunomodulator agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
Click Here to get the full Stock Score Report on IMMURON LTD/S ADR (IMRN) Stock.
